CHRU de Nancy

Vandœuvre-lès-Nancy 54511

1 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), Crohn's Disease, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Higher-Risk Myelodysplastic Syndrome (HR-MDS), Mantle Cell Lymphoma (MCL), Marginal Zone Lymphoma (MZL), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Colorectal Cancer (mCRC), Newly Diagnosed Intermediate/High-Risk MDS, Primary Central Nervous System Lymphoma (PCNSL)

Studies at this site

• A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies — Recruiting now
• Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis — Stopped early